Artwork

Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How Amish People Informed a COVID-19 Clinical Trial with Douglas Vaughan, MD

22:14
 
Share
 

Manage episode 275491161 series 2399388
Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

A Swiss Amish community in Indiana has been the focus of ongoing studies led by Dr. Douglas Vaughan, chair of the Department of Medicine at Northwestern. Many members of this Amish community have a gene mutation that appears to protect against biological aging in a variety of ways. A new experimental drug that effectively lowers the level of the protein associated with this mutation is now being tested as a treatment for people with COVID-19, in a phase 2 clinical trial at Northwestern.

  continue reading

107 episodes

Artwork
iconShare
 
Manage episode 275491161 series 2399388
Content provided by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Feinberg School of Medicine and Northwestern University Feinberg School of Medicine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

A Swiss Amish community in Indiana has been the focus of ongoing studies led by Dr. Douglas Vaughan, chair of the Department of Medicine at Northwestern. Many members of this Amish community have a gene mutation that appears to protect against biological aging in a variety of ways. A new experimental drug that effectively lowers the level of the protein associated with this mutation is now being tested as a treatment for people with COVID-19, in a phase 2 clinical trial at Northwestern.

  continue reading

107 episodes

すべてのエピソード

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide